相关实验视频

Updated: Jun 28, 2026

Intra-Omental Islet Transplantation Using h-Omental Matrix Islet filliNG (hOMING)

Intra-Omental Islet Transplantation Using h-Omental Matrix Islet filliNG (hOMING)

Published on: March 14, 2019

水凝敷料作为糖尿病伤口的胰岛素输送系统

Agnieszka Kłapcia¹, Patrycja Domalik-Pyzik²

¹Academic Centre for Materials and Nanotechnology, AGH University of Krakow, 30-059 Krakow, Poland.

Frontiers in bioscience (Elite edition)

|March 28, 2025

概括

由于炎症和感染,糖尿病伤口很难愈合. 提供胰岛素的创新水凝包裹显示出通过促进愈合和减少炎症来治疗这些具有挑战性的伤口的希望.

科学领域:

生物医学工程生物医学工程
伤口治愈研究研究伤口治愈研究
糖尿病并发症糖尿病并发症

背景情况:

糖尿病伤口由于长时间的炎症,血管新生障碍,异常组织再生和高感染率而存在重大挑战.
组织葡萄糖水平升高会加剧炎症,破坏信号传递,导致异常细胞分化,阻碍自然愈合过程.
传统的伤口包裹往往对高度排泄的糖尿病伤口不够,频繁的改变可能会导致进一步的刺激.

研究的目的:

审查糖尿病和糖尿病伤口病理生理学的复杂性.
评估糖尿病伤口管理的传统和创新治疗策略.
突出水凝敷料作为糖尿病伤口治疗的胰岛素输送系统的潜力.

主要方法:

关于糖尿病的综合文献综述,糖尿病伤口的特征和治疗方式.
对水凝特性及其适用性作为伤口包装材料的分析.
检查胰岛素在伤口愈合中的作用及其通过水凝控制释放的潜力.

主要成果:

水凝为组织再生和治疗剂的控制释放提供了合适的基质.
胰岛素表现出有益的作用,包括与伤口愈合相关的抗炎,益血管和细胞刺激性质.
用于输送胰岛素的葡萄糖反应性水凝系统是一个有前途的创新方法.

结论:

水凝敷料是先进的伤口护理系统,有可能增强糖尿病伤口愈合.
载有胰岛素的水凝通过利用胰岛素的多方面的伤口愈合特性,提供了有针对性的治疗策略.
为了有效的糖尿病伤口管理,对对葡萄糖敏感的水凝基胰岛素输送系统进行进一步的研究是有必要的.

关键词:

糖尿病伤口糖尿病伤口药物输送系统是药物输送系统.水凝包装剂水凝包装剂胰岛素的胰岛素胰岛素是什么通过刺激控制释放.

更多相关视频

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

Glucose-Stimulated Insulin Secretion via Perfusion through the Mice Vasculature with an Intact Pancreas

Glucose-Stimulated Insulin Secretion via Perfusion through the Mice Vasculature with an Intact Pancreas

Published on: July 25, 2025

相关概念视频

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...

Glucagon-like Receptor Agonists

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...

Hypoglycemia

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...

Diabetic Retinopathy

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...

Diabetic Nephropathy

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...

Diabetic Neuropathy

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...